5 research outputs found

    Influence of feeding regimens on rat gut fluids and colonic metabolism of diclofenac-β-cyclodextrin

    Get PDF
    Feeding states may affect the performance of colonic prodrugs. The aim is to investigate the influence of feeding regimen in Wistar rats on: (i) distribution and pH contents along the gut and (ii) metabolism of two colonic prodrugs, diclofenac-β-cyclodextrin and a commercially available control, sulfasalazine, within the caecal and colonic contents. Male Wistar rats were subject to four different feeding regimens, the gut contents characterized (mass and pH) and the metabolism of prodrugs investigated. The feeding regimen affects gut contents (mass and pH), more specifically in the stomach and lower intestine, and affects the rate of metabolism of diclofenac-β-cyclodextrin, but not that of sulfasalazine. The latter's degradation is much faster than that of diclofenac-β-cyclodextrin while the metabolism of both prodrugs is faster in colonic (versus caecal) contents. Fasting results in most rapid degradation of diclofenac-β-cyclodextrin, possibly due to lack of competition (absence of food) for microbial enzymatic activity

    On the mechanism of carboxylic acid co-catalyst assisted metalloporphyrin oxidations

    Get PDF
    The role of the carboxylic acid as co-catalyst in metalloporphyrin catalytic hydrogen peroxide oxidations is discussed, taking into account its dependence on the ratio relatively to the catalyst. The catalytic efficiency and stability of the catalyst in the presence of an excess of carboxylic acid suggests that a metallo-acylperoxo complex can be the effective oxidation intermediate.http://www.sciencedirect.com/science/article/B6TGM-42G6XGY-4/1/0ef5cfc94471f6985d77385ef339282

    A nonionic porphyrin as a noninterfering DNA antibacterial agent

    No full text
    The increasing interest in clinical bacterial photodynamic inactivation has led to the search for photosensitizers with higher bactericidal efficiency and less side effects on the surrounding tissues. We present a novel nonionic porphyrin, the 5,10,15‐tris(2,6‐dichlorophenyl)‐20‐[4‐N‐(6‐amino‐hexyl)sulfonamido)phenyl]‐porphyrin (ACS769F4) with substantial improvements in the efficiency of nonionic sensitizers. This porphyrin causes eradication of both Escherichia coli and Staphylococcus aureus by the photodynamic effect but in higher concentrations compared with 5,10,15,20‐tetrakis (4‐N,N,N‐trimethylammoniumphenyl)‐porphyrin p‐tosylate (TTAP4+), a known bactericidal tetracationic porphyrin. More important, under such conditions, ACS769F4 proved to be harmless to two mammalian cells lines (human embryonic and baby hamster kidney), causing no reduction in their viability or negative impact on their cytoskeleton, despite its accumulation in cellular structures. On the contrary, TTAP4+ is shown to accumulate in the nucleus of mammalian cells, in association to DNA, causing chromatin condensation after exposure to light. Furthermore, dark incubation with TTAP4+ was shown to have a deleterious effect on the microtubule network. Based on its bactericidal efficiency, also observed without exposure to light, and on the low tendency to be harmful or genotoxic to mammalian cells, ACS769F4 should be looked at as an interesting photosensitizer to be evaluated for clinical purposes.info:eu-repo/semantics/publishedVersio
    corecore